-
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
-
ChemBase ID:
72831
-
Molecular Formular:
C18H24BrNO4
-
Molecular Mass:
398.29146
-
Monoisotopic Mass:
397.08887025
-
SMILES and InChIs
SMILES:
[Br-].[C@@H]12[C@@H]3[C@H]([C@@H]([N+]1(C)C)C[C@@H](C2)OC(=O)[C@@H](c1ccccc1)CO)O3
Canonical SMILES:
OC[C@H](c1ccccc1)C(=O)O[C@@H]1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3.[Br-]
InChI:
InChI=1S/C18H24NO4.BrH/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11;/h3-7,12-17,20H,8-10H2,1-2H3;1H/q+1;/p-1/t12-,13-,14?,15?,16-,17+;/m1./s1
InChIKey:
CXYRUNPLKGGUJF-IWBLJBMISA-M
-
Cite this record
CBID:72831 http://www.chembase.cn/molecule-72831.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
|
|
|
IUPAC Traditional name
|
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
|
|
|
Synonyms
|
Scopolamine methyl bromide
|
Pamine
|
Methscopolamine bromide
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
15.14574
|
H Acceptors
|
3
|
H Donor
|
1
|
LogD (pH = 5.5)
|
-3.2673843
|
LogD (pH = 7.4)
|
-3.2673843
|
Log P
|
-3.2673843
|
Molar Refractivity
|
95.6349 cm3
|
Polarizability
|
33.79425 Å3
|
Polar Surface Area
|
59.06 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
Storage Condition
|
-20°C
|
Show
data source
|
|
Salt Data
|
bromide
|
Show
data source
|
|
DETAILS
DETAILS
Selleck Chemicals
Selleck Chemicals -
S1978
|
Research Area: Neurological Disease Biological Activity: Methscopolamine (Pamine)is a muscarinic acetylcholine receptors blocker. It is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. It also may work directly on the vomiting center. Methscopolamine bromide must be taken before the onset of motion sickness to be effective. It acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center). [1] |
PATENTS
PATENTS
PubChem Patent
Google Patent